BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10448603)

  • 61. Cytogenetic studies on human myeloma cell lines.
    Jernberg H; Zech L; Nilsson K
    Int J Cancer; 1987 Dec; 40(6):811-7. PubMed ID: 3500922
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chromosomal abnormalities clustering in multiple myeloma reveals cytogenetic subgroups with nonrandom acquisition of chromosomal changes.
    Sáez B; Martín-Subero JI; Guillén-Grima F; Odero MD; Prosper F; Cigudosa JC; Harder L; Calasanz MJ; Siebert R
    Leukemia; 2004 Mar; 18(3):654-7. PubMed ID: 14712294
    [No Abstract]   [Full Text] [Related]  

  • 63. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlations between karyotype and cytologic findings in multiple myeloma.
    Weh HJ; Bartl R; Seeger D; Selbach J; Kuse R; Hossfeld DK
    Leukemia; 1995 Dec; 9(12):2119-22. PubMed ID: 8609726
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chromosomal abnormalities in multiple myeloma.
    Ranjini R
    J Kans Med Soc; 1971 Nov; 72(11):435-7. PubMed ID: 5120691
    [No Abstract]   [Full Text] [Related]  

  • 66. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
    Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endometrial stromal sarcoma with clonal complex chromosome abnormalities. Report of a case and review of the literature.
    Sonobe H; Iwata J; Furihata M; Ohtsuki Y; Taguchi T; Shimizu K
    Cancer Genet Cytogenet; 1999 Jul; 112(1):34-7. PubMed ID: 10432932
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Significance of chromosomal abnormalities in a malignant giant cell tumor of bone.
    Bridge JA; Mouron BJ; Neff JR; Bhatia PS
    Cancer Genet Cytogenet; 1991 Nov; 57(1):87-92. PubMed ID: 1756489
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multicolor fluorescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Gutiérrez NC; Camps J; Hernández JM; García JL; Prat E; González MB; Miró R; San Miguel JF
    Hematol J; 2003; 4(1):67-70. PubMed ID: 12692523
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.
    Fonseca R; Hoyer JD; Aguayo P; Jalal SM; Ahmann GJ; Rajkumar SV; Witzig TE; Lacy MQ; Dispenzieri A; Gertz MA; Kyle RA; Greipp PR
    Leuk Lymphoma; 1999 Nov; 35(5-6):599-605. PubMed ID: 10609798
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate.
    Lundgren R; Kristoffersson U; Heim S; Mandahl N; Mitelman F
    Cancer Genet Cytogenet; 1988 Oct; 35(1):103-8. PubMed ID: 3180000
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance.
    Schilling G; Dierlamm J; Hossfeld DK
    Hematol Oncol; 2005; 23(3-4):102-7. PubMed ID: 16342296
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
    Jimenez-Zepeda VH; Braggio E; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A modified cytogenetic study for multiple myeloma].
    Qin YW; Wei DL; Wang C; Yan SK; Gao YR; Cai Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):213-5. PubMed ID: 16604501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
    Wiktor A; Van Dyke DL
    Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
    Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
    Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A case of no-anomaly type multiple myeloma with marked chromosomal abnormalities].
    Nakayama S; Hattori Y; Itani S; Hoshino T
    Nihon Ketsueki Gakkai Zasshi; 1973 Apr; 36(2):139-49. PubMed ID: 4738465
    [No Abstract]   [Full Text] [Related]  

  • 78. [Detection of chromosomal aberrations in multiple myeloma with fluorescence in situ hybridization].
    Cao P; Chen F; Cheng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 37(10):983-9. PubMed ID: 23117450
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multiple myeloma associated with amyloidosis and t(1;20)(q21;q11) translocation.
    Otokida K; Yoshida H; Mizunuma Y; Yamada M; Hiramori K
    Tohoku J Exp Med; 1990 Dec; 162(4):363-5. PubMed ID: 2102567
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
    Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
    Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.